Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P512: Results of interim analysis of a retrospective IGIBD study on adalimumab use in real practice in Italy: the REAL-life clinical effectiveness of ADAlimumab in ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

D. Pugliese1, M. Mendolaro2, R. D'Incà3, D. G. Ribaldone4, M. Principi5, C. Ricci6, E. Stasi7, M. L. Scribano8, G. Bodini9, S. Saibeni10, A. C. Privitera11, D. Simondi12, A. Armuzzi1, M. Daperno*2, Italian Group for Inflammatory Bowel Disease (IGIBD)1

1Fondazione Policlinico Gemelli IRCCS, Gastroenterology, Rome, Italy, 2Mauriziano Hospital, Gastroenterology Unit, Torino, Italy, 3Padua University, Gastroenterology Unit, Padua, Italy, 4Città della Scienza e della Salute, Gastroenterology Unit, Torino, Italy, 5Bari University, Gastroenterology Unit, Bari, Italy, 6Spedali Civili, Internal Medicine, Brescia, Italy, 7IRCCS De Bellis, Gastroenterology Unit, Castellana Grotte, Italy, 8S. Camillo-Forlanini Hospital, Gastroenterology Unit, Rome, Italy, 9Genova University Hospital, Gastroenterology Unit, Genova, Italy, 10Rho Hospital, Gastroenterology Unit, Rho, Italy, 11Cannizzaro Hospital, Gastroenterology, Catania, Italy, 12S. Croce and Carle Hospital, Gastroenterology Unit, Cuneo, Italy

P513: Performance of a rapid test for adalimumab monitoring vs. conventional ELISA in a routine laboratory setting

ECCO '19 Copenhagen

Year: 2019
Authors:

T. Van Stappen*1, B. H. Roovers2, F. van Deurzen2, A. J. van Vuuren2

1R-Biopharm AG, Clinical Diagnostics, Darmstadt, Germany, 2Erasmus MC, Gastroenterology and Hepatology Diagnostic Laboratory, Rotterdam, The Netherlands

P514: Health Care Transition outcomes in inflammatory bowel disease: an international Delphi study

ECCO '19 Copenhagen

Year: 2019
Authors:

G. van den Brink1, M. van Gaalen1, L. de Ridder1, J. Escher*1, J. van der Woude2

1Erasmus MC-Sophia Children’s Hospital, Paediatric Gastroenterology, Rotterdam, The Netherlands, 2Erasmus MC, Department of Gastroenterology, Rotterdam, The Netherlands

P515: Costs associated with the management of refractory complex perianal fistulas in patients with Crohn's disease

ECCO '19 Copenhagen

Year: 2019
Authors:

M. D. Martín-Arranz*1, I. Pascual Migueláñez1, J. L. Marijuán1

1Hospital Universitario La Paz, Servicio de Ap. Digestivo, Madrid, Spain

P516: The use of first-line biologics in patients with ulcerative colitis in Norway from 2011 to 2016

ECCO '19 Copenhagen

Year: 2019
Authors:

K. Anisdahl*1,2, S. Lirhus3, A. Medhus1, L. Buer1,2, H. O. Melberg3, B. Moum1,2, M. Lie Høivik1

1Oslo University Hospital, Department of Gastroenterology, Oslo, Norway, 2University of Oslo, Institute of Clinical Medicine, Oslo, Norway, 3University of Oslo, Institute of Health and Society, Oslo, Norway

P517: Activity assessment in ulcerative colitis: correlation analysis of endoscopic and histological scores

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Di Ruscio*1, A. Variola1, A. Geccherle1, S. Orlandi1, G. Lunardi2, P. Castelli3, G. Zamboni3, R. Riddell4

1IRCCS Sacro Cuore Don Calabria, IBD Unit, Negrar, Italy, 2IRCCS Sacro Cuore Don Calabria, Division of Medical Oncology, Negrar, Italy, 3IRCCS Sacro Cuore Don Calabria, Department of Pathology, Negrar, Italy, 4Mount Sinai Hospital University of Toronto, Department of Pathology and Laboratory Medicine, Toronto, Canada

P518: Cardiovascular Risk Factors in Adolescents with inflammatory bowel disease: A Cross-sectional Population-Based Study

ECCO '19 Copenhagen

Year: 2019
Authors:

I. Ghersin*1, L. H. Katz2,3, S. Daher4, R. Shamir3,5, A. Assa3,5

1Rambam Health Care Campus, Department of Gastroenterology, Haifa, Israel, 2Sheba Medical Center, Department of Gastroenterology, Ramat Gan, Israel, 3Tel Aviv University, The Sackler School of Medicine, Tel Aviv, Israel, 4IDF Medical Corps, Tel Hashomer, Israel, 5Schneider Children's Medical Center, Institute of Gastroenterology, Nutrition and Liver Disease, Petach Tikva, Israel

P519: Post-surgical recurrence predictors in the years 2000. Results of a retrospective single-centre long-term follow-up series and impact of imaging findings on outcomes

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Mendolaro*1, M. Daperno1, C. Randazzo2, A. Lavagna1, M. Mineccia3, M. Cosimato1, F. Bertolino4, C. Rigazio1, E. Ercole1, A. Ferrero3, R. Rocca1

1Mauriziano Hospital, Gastroenterology Unit, Torino, Italy, 2Istituto Cinico Locorotondo, Gastroenterology and Endoscopy, Palermo, Italy, 3Mauriziano Hospital, Surgery, Turin, Italy, 4ASL CN1 Savigliano Hospital, Surgery, Savigliano, Italy

P520: Endoscopic evaluation and factors affecting the endoscopic efficacy during granulomonocytapheresis in moderately-to-severely active ulcerative colitis: a multi-centre retrospective study

ECCO '19 Copenhagen

Year: 2019
Authors:

T. Yamamoto1, T. Iida2, K. Ikeya2, M. Kato2, A. Matsuura2, S. Tamura3, R. Takano3, S. Tani4, S. Osawa4, K. Sugimoto3, T. Shimoyama*1, H. Hanai2

1Yokkaichi Hazu Medical Centre, IBD Centre, Yokkaichi, Japan, 2Hamamatsu South Hospital, Center for Gastroenterology and Inflammatory Bowel Disease Research, Hamamastu, Japan, 3Hamamatsu University School of Medicine, First Department of Medicine, Hamamatsu, Japan, 4Hamamatsu University School of Medicine, Department of Endoscopic and Photodynamic Medicine, Hamamatsu, Japan

P521: Pre-operative enteral nutrition in adults with Crohn’s disease: effect on gut microbiota and disease outcomes

ECCO '19 Copenhagen

Year: 2019
Authors:

M. P. Costa Santos*1, C. Palmela1, J. Torres1, A. Ferreira1, S. Velho1, L. Glória1, S. Ouro1, I. Gordo2, M. Cravo1

1Hospital Beatriz Ângelo, Loures, Portugal, 2Instituto Gulbenkian de Ciência, Lisboa, Portugal

P522: Expression of markers of early atherosclerosis in inflammatory bowel disease: a prospective cohort of a single referral centre

ECCO '19 Copenhagen

Year: 2019
Authors:

B. Scrivo*1, M. G. Cilluffo1, A. Tuttolomondo2, D. Torres2, V. Calvaruso1, A. Pinto2, M. Cappello3

1University of Palermo, Gastroenterology Section, DiBiMis, Palermo, Italy, 2University of Palermo, Internal Medicine and Cardioangiology, DiBiMis, Palermo, Italy, 3University of Palermo - Italy, Gastroenterology Section, DiBiMis, Palermo, Italy

P523: Endoscopic balloon dilatation is safe and has a high success rate in patients with stricturing Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

E. Lim1,2,3, M. Thai2,4, P. Hendy2,4, M. Alchlaihawi5, R. Leong5,6,7, S. Connor6,8, W. Ng6,8, B. Gu6,8, D. van Langenberg9,10, L. Thin11,12, J. Schulberg13,14, M. Kamm13,14, R. Gilmore15, K. Taylor15, O. Sallis16,17, J. Andrews16,17, C. Daker18,19, M. Barclay18,19, G. Wark6,20, S. Ghaly6,20, M. Begun6, K. Krishnaprasad21, J. Begun*2,4,22

1Queen Elizabeth II Jubilee Hospital, Gastroenterology, Brisbane, Australia, 2The University Of Queensland, Faculty of Medicine, Brisbane, Australia, 3James Cook University, College of Medicine and Dentistry, Townsville, Australia, 4Mater Hospital Brisbane, Gastroenterology, Brisbane, Australia, 5Concord Repatriation General Hospital,, Sydney, Australia, 6University of New South Wales, Faculty of Medicine, Sydney, Australia, 7Macquarie University, Faculty of Medicine and Health Sciences, Sydney, Australia, 8Liverpool Hospital, Gastroenterology, Sydney, Australia, 9Eastern Health, Gastroenterology, Melbourne, Australia, 10Monash University, Faculty of Medicine, Nursing and Health Sciences, Melbourne, Australia, 11Fiona Stanley Hospital, Gastroenterology, Perth, Australia, 12University of Western Australia,, Faculty of Health and Medical Sciences, Perth, Australia, 13St Vincent’s Hospital, Gastroenterology, Melbourne, Australia, 14University of Melbourne, Faculty of Medicine, Dentistry and Health Sciences, Melbourne, Australia, 15The Alfred, Gastroenterology, Melbourne, Australia, 16Royal Adelaide Hospital, Gastroenterology, Adelaide, Australia, 17University of Adelaide, Faculty of Health and Medical Sciences, Adelaide, Australia, 18Christchurch Hospital, Gastroenterology, Christchurch, New Zealand, 19University of Otago, Department of Medicine, Christchurch, New Zealand, 20St Vincent’s Hospital, Gastroenterology, Sydney, Australia, 21QIMR Berghofer, Brisbane, Australia, 22Mater Research Institute - UQ, Brisbane, Australia

P524: Systematic review of calcineurin inhibitors (CNI) and vedolizumab (VDZ) combination therapy in acute severe ulcerative colitis (ASUC)

ECCO '19 Copenhagen

Year: 2019
Authors:

H. Lin*1, W-C. Lim1

1Tan Tock Seng Hospital, Gastroenterology and Hepatology, Singapore, Singapore

P525: The benefits of anti-TNF drug and antidrug antibody (ADAb) level monitoring in a DGH

ECCO '19 Copenhagen

Year: 2019
Authors:

C. Matthews*1, I. London1, I. Reilly1, T. Maheswaren1, A. Lewis Williams1, S. Michail1

1Countess of Chester Hospital, Chester, UK

P526: Survey of adherence to treatment in inflammatory bowel disease: ENADEII STUDY

ECCO '19 Copenhagen

Year: 2019
Authors:

I. Alonso Abreu*1, O. Alarcón-Fernández1, M. Carrillo-Palau1, L. Ramos López1, J. P. Gisbert2, M. Chaparro2, P. Nos3, A. Jiménez Sosa4, E. Quintero Carrión1, GETECCU1

1Hospital Universitario de Canarias, Gastroenterology, Santa Cruz de Tenerife, Spain, 2Hospital Universitario La Princesa. IIS-IP, CIBEREHD, Gastroenterology, Madrid, Spain, 3Hospital Universitario La Fe, Gastroenterology, Valencia, Spain, 4Hospital Universitario de Canarias, Statistics, Santa Cruz de Tenerife, Spain

P527: Body image dissatisfaction is increased in inflammatory bowel disease compared with healthy matched controls but not diseased controls

ECCO '19 Copenhagen

Year: 2019
Authors:

H. Su*1, A. Chen1, S. Brown1, J. Alcantara1, D. Sim2, H. Myint1, P. Lilic1, S. Inns1,2

1Hutt Valley Hospital, Gastroenterology Department, Lower Hutt, New Zealand, 2University of Otago, Department of Medicine, Wellington, New Zealand

P529: Exposure–response relationship of vedolizumab subcutaneous treatment in patients with ulcerative colitis: VISIBLE 1

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Rosario1, D. Polhamus2, N. Dirks2, R. Lock3, X. Yao1, J. Chen1, C. Chen1, W. Sun1, B. Feagan4, W. Sandborn5, G. D’Haens*6

1Takeda Development Center Americas Inc., Cambridge, USA, 2Metrum Research Group, Tariffville, USA, 3Aucuba Sciences, Ltd.,, Canterbury, Kent, UK, 4Robarts Clinical Trials, Robarts Research Institute, University of Western Ontario, London, ON, Canada, 5University of California San Diego, La Jolla, USA, 6Amsterdam University Medical Centers, Amsterdam, The Netherlands

P530: Ultra-proactive therapeutic drug monitoring incorporating infliximab point-of-care testing with ad hoc dose adjustment reduces C-reactive protein levels in patients with IBD during infliximab maintenance treatment

ECCO '19 Copenhagen

Year: 2019
Authors:

P. Bossuyt*1,2, E. Hoefkens2, I. Geerts3, F. Verbiest4, E. Vermeulen3, A. Van Olmen2, L. Pouillon2

1University Hospitals Leuven, Catholic University of Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium, 2Imelda General Hospital, Department of Gastroenterology, Bonheiden, Belgium, 3Imelda General Hospital, Department of Laboratory Medicine, Bonheiden, Belgium, 4Imelda General Hospital, Central Hospital Pharmacy, Bonheiden, Belgium

P531: Efficacy of tofacitinib maintenance therapy for ulcerative colitis in remitting patients vs. patients with clinical response after 8 weeks of induction treatment

ECCO '19 Copenhagen

Year: 2019
Authors:

W. Reinisch*1, M. T. Osterman2, G. Doherty3, A. Marren4, D. A. Woodworth4, N. Lawendy4, K. Kwok5, E. Maller4, C. Su4

1Medical University of Vienna, Vienna, Austria, 2Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA, 3St Vincent's University Hospital, University College Dublin, Dublin, Ireland, 4Pfizer Inc., Collegeville, PA, USA, 5Pfizer Inc., New York, NY, USA

P532: Safety and efficacy of endoscopic dilation of small bowel Crohn’s disease strictures by balloon-assisted enteroscopy: pooled analysis of individual data from 210 patients

ECCO '19 Copenhagen

Year: 2019
Authors:

D. Bettenworth*1, A. Bokemeyer1, L. Kou2, R. Lopez2, B. P. Halloran3, M. Reeson3, S. Hosomi4, M. Kishi5, F. Hirai5, N. Ohmiya6, F. Rieder7,8

1University Hospital Münster, Department of Medicine B, Gastroenterology and Hepatology, Münster, Germany, 2Cleveland Clinic Foundation, Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland, USA, 3University of Alberta, Division of Gastroenterology, Edmonton, Canada, 4Osaka City University Graduate School of Medicine, Department of Gastroenterology, Osaka, Japan, 5Fukuoka University Chikushi Hospital, Chikushino, Inflammatory Bowel Disease Center, Fukuoka, Japan, 6Fujita Health University School of Medicine, Department of Gastroenterology, Toyoake city, Japan, 7Cleveland Clinic Foundation, Department of Gastroenterology, Hepatology and Nutrition, Digestive Disease Institute, Cleveland, USA, 8Cleveland Clinic Foundation, Department of Pathobiology, Lerner Research Institute, Cleveland, USA